|
Volumn 29, Issue 8, 2011, Pages 690-
|
Reply to: IMI moves forward
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOTECHNOLOGY;
CELL THERAPY;
DRUG INDUSTRY;
EMPLOYEE;
EXPERIMENTAL THERAPY;
HEALTH CARE ORGANIZATION;
LETTER;
NATURAL SCIENCE;
PLURIPOTENT STEM CELL;
PRIORITY JOURNAL;
RISK ASSESSMENT;
|
EID: 79961180771
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt.1951 Document Type: Letter |
Times cited : (11)
|
References (0)
|